AI Foresights — A New Dawn Is Here
Back to homebest ai tools

FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder

TechCrunch AI Maggie Nye, Isabelle Johannessen April 30, 2026
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
AI Summary— plain English for professionals

# BioticsAI Founder on Why Healthcare AI Is Hard (But Worth It) A startup called BioticsAI has figured out how to get AI tools approved by the FDA and funded by investors while dealing with healthcare's strict regulations—a challenge that stops many AI companies in their tracks. The company's CEO shared practical lessons about what it takes to build AI products in healthcare, including patience with bureaucracy and keeping your team motivated through the slow approval process. For anyone considering AI in regulated industries, his experience shows both the obstacles and opportunities that exist when you're willing to navigate the rules.

BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.

Read full article on TechCrunch AI

Get new guides every week

Real AI income strategies, tool reviews, and plain-English news — free in your inbox.

or enter email